NCT01597947View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

ACHN-975

Intravenous single dose

DRUG

placebo

Intravenous single dose

Trial Locations (1)

27705

Investigational Site, Durham

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
collaborator

Defense Medical Research and Development Program

UNKNOWN

lead

Achaogen, Inc.

INDUSTRY